Globus Medical, Inc.
US ˙ NYSE ˙ US3795772082

SecurityGMED / Globus Medical, Inc.
InstitutionJJJ Advisors Inc.
Latest Disclosed Ownership289 shares
Latest Disclosed Value $ 19,794
JJJ Advisors Inc. ownership in GMED / Globus Medical, Inc.

On July 25, 2024 - JJJ Advisors Inc. filed a 13F-HR form disclosing ownership of 289 shares of Globus Medical, Inc. (US:GMED) valued at $19,794 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 15, 2024 disclosing 289 shares of Globus Medical, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $23,120 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-25 2024-06-30 13F GLOBUS MED CL A 379577208 289 0 0.00 20 26.67 0.0041
2024-04-15 2024-03-31 13F GLOBUS MED CL A 379577208 289 -38 -11.62 16 -11.76 0.0033
2024-01-29 2023-12-31 13F GLOBUS MED CL A 379577208 327 231 240.62 17 325.00 0.0042
2023-10-13 2023-09-30 13F GLOBUS MED CL A 379577208 96 -127 -56.95 5 -69.23 0.0013
2023-07-11 2023-06-30 13F GLOBUS MED CL A 379577208 223 -515 -69.78 13 -69.05 0.0037
2023-04-21 2023-03-31 13F GLOBUS MED CL A 379577208 738 -646 -46.68 42 -58.42 0.0120
2023-01-23 2022-12-31 13F GLOBUS MED CL A 379577208 1,384 7 0.51 102 26.25 0.0287
2022-10-17 2022-09-30 13F GLOBUS MED CL A 379577208 1,377 752 120.32 80 116.22 0.0261
2022-08-03 2022-06-30 13F GLOBUS MED CL A 379577208 625 -203 -24.52 37 -39.34 0.0110
2022-05-05 2022-03-31 13F GLOBUS MED CL A 379577208 828 436 111.22 61 117.86 0.0168
2022-02-02 2021-12-31 13F GLOBUS MED CL A 379577208 392 93 31.10 28 21.74 0.0084
2021-10-25 2021-09-30 13F/A-1 GLOBUS MED CL A 379577208 299 88 41.71 23 43.75 0.0081
2021-10-19 2021-09-30 13F GLOBUS MED CL A 379577208 299 88 23 0.0081
2021-07-28 2021-06-30 13F GLOBUS MED CL A 379577208 211 55 35.26 16 60.00 0.0058
2021-04-28 2021-03-31 13F GLOBUS MED CL A 379577208 156 -14 -8.24 10 -9.09 0.0040
2021-01-26 2020-12-31 13F GLOBUS MED CL A 379577208 170 110 183.33 11 266.67 0.0053
2020-10-19 2020-09-30 13F GLOBUS MED CL A 379577208 60 60 3 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.